[Controversy and consensus on antiviral treatment strategies for low-level hepatitis B surface antigens]. [PDF]
Zhonghua Gan Zang Bing Za ZhiHou YH, Zhang LY.
europepmc +1 more source
[Tenofovir amibufenamide treatment for three cases with chronic hepatitis B]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLyu MJ, Qiu J.
europepmc +1 more source
[Introduction of the key update points of the 2025 Canadian Association for the Study of the Liver guideline for the management of chronic hepatitis B]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhuang H.
europepmc +1 more source
[A case of hepatitis B surface antigen clearance achievement based on the combination of interferon and intermittent consolidation therapy]. [PDF]
Zhonghua Gan Zang Bing Za ZhiDeng W +5 more
europepmc +1 more source
[Comparison of antiviral efficacy of nucleos(t)ide analogue monotherapy and its combination with interferon-α in children 1-6 years-old with HBeAg-positive chronic hepatitis B]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang ZW +11 more
europepmc +1 more source
[Research progress on hepatitis B combined with C and its treatment]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLin Q +6 more
europepmc +1 more source
[Reflections on the novel definition and whether or not antiviral therapy for inactive HBsAg carrier state in the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)"]. [PDF]
Zhonghua Gan Zang Bing Za ZhiRen S, Zheng SJ, Chen XY.
europepmc +1 more source
[Study on the value of abnormal prothrombin in the diagnosis of HBV-related hepatocellular carcinoma]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhang JM +8 more
europepmc +1 more source
[Icariside Ⅱ Inhibits Hepatitis B Virus and Modulates Mitochondrial Fission <i>in vitro</i>]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanLiu Z +6 more
europepmc +1 more source